The machine health technology provider was reportedly valued at up to $300m in a series D round featuring Qualcomm Ventures and Munich Re Venture Capital.

Augury, an Israel-headquartered developer of machine analysis technology, raised $55m in series D funding on Wednesday from investors including subsidiaries of mobile semiconductor producer Qualcomm and reinsurer Munich Re. Qualcomm Ventures and Munich Re Venture Capital joined venture capital firm Qumra Capital, which led the round, Insight Partners, Eclipse Ventures and Lerer Hippeau. A source…

The rest of this content is only accessible to Global Corporate Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.